Cognitive Behavioral Therapy for Asthma and Depression
What You Need to Know Before You Apply
What is the purpose of this trial?
Depressive disorders are highly prevalent among older adults with asthma and are associated with poor asthma outcomes. The overall objective of this study is to integrate an asthma self-management support program that the research team previously developed with cognitive behavioral therapy (CBT) for adherence and depression for older adults with uncontrolled asthma and a comorbid depressive disorder. The research team will conduct a pilot randomized controlled trial to assess the feasibility and preliminary impact of the intervention on asthma and depression outcomes.
Who Is on the Research Team?
Juan Wisnivesky, MD
Principal Investigator
Icahn School of Medicine at Mount Sinai
Are You a Good Fit for This Trial?
This trial is for older adults who have both uncontrolled asthma and depression. Participants should be able to take part in therapy sessions and manage their own asthma care.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Cognitive Behavioral Therapy-Asthma Depression (CBT-AD)
- Original SAMBA
- SAMBA
Trial Overview
The study is testing a combined program that includes cognitive behavioral therapy (CBT) for depression along with an asthma self-management support program, compared to standard versions of the self-management program. Participants are randomly assigned to different groups.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants will receive the SAMBA and CBT-AD intervention.
Participants will receive the original SAMBA intervention.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Icahn School of Medicine at Mount Sinai
Lead Sponsor
Yeshiva University
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.